A team of researchers from Hiroshima University has discovered a molecule that promotes the production of cancer cells. This molecule may prove to be a potential therapeutic target in the treatment of triple-negative breast ...
Mar 28, 2024
0
0
At around 20 weeks of pregnancy women with a short cervix have an increased risk of preterm birth. Preventing preterm birth in pregnant women with a short cervix is a crucial step in protecting the health of the child. Research ...
Mar 12, 2024
0
31
Research from the University of Virginia School of Medicine could pave the way for new treatments to manage migraines and chronic pain in women, improving their quality of life. The work is published in The Journal of Pain.
Feb 21, 2024
0
4
The use of oral contraception containing a synthetic form of progesterone (progestogen) may lead to an increased risk of suicidal behavior for women with depression and suicidal ideations. Researchers at the Netherlands Institute ...
Feb 12, 2024
0
1
Combined oral contraceptives (COCs) are associated with higher risks for developing irritable bowel syndrome (IBS) and its subtypes, according to a study presented at the annual meeting of the American College of Gastroenterology, ...
Oct 24, 2023
0
0
Zachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogenesis Program of the Ellen and Ronald Caplan Cancer Center at The Wistar Institute, has published a new paper in the journal Nature Cancer. Schug's ...
Sep 18, 2023
0
134
TNBC is a particularly aggressive subtype of breast cancer, characterized by the absence of three key receptors: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Approximately ...
Jul 25, 2023
0
1
How TTP488 (azeliragon), an experimental drug, impairs aggressive, triple-negative breast cancer from metastasizing has been uncovered at the cellular level, according to researchers at Georgetown University's Lombardi Comprehensive ...
Jul 18, 2023
0
44
A new research perspective was published in Oncotarget, titled "Deciphering the mechanisms of action of progesterone in breast cancer."
Jul 10, 2023
0
0
A new editorial paper titled "ERβ as a mediator of estrogen signaling in inflammatory breast cancer" has been published in Oncotarget.
Jul 3, 2023
0
1
Progesterone also known as P4 (pregn-4-ene-3,20-dione) is a C-21 steroid hormone involved in the female menstrual cycle, pregnancy (supports gestation) and embryogenesis of humans and other species. Progesterone belongs to a class of hormones called progestogens, and is the major naturally occurring human progestogen.
Progesterone is commonly manufactured from the yam family, Dioscorea. Dioscorea produces large amounts of a steroid called diosgenin, which can be converted into progesterone in the laboratory.
This text uses material from Wikipedia, licensed under CC BY-SA
